Idorsia (XSWX:IDIA) Enterprise Value: CHF2,760.2 Mil (As of Jun. 26, 2026) ***


XSWX:IDIA Idorsia Ltd XSWX:IDIA
49 GF Score
Price CHF6.02
GF Value CHF2.85
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Idorsia Enterprise Value?

Idorsia XSWX:IDIA +2.56% 49 Enterprise Value is CHF2,760.2 Mil as of Jun. 26, 2026. GuruFocus rates XSWX:IDIA with a GF Score™ of 49/100 and a GF Value™ of CHF2.85 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Idorsia's Enterprise Value is CHF2,760.2 Mil. Idorsia's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was CHF-67.2 Mil. Therefore, Idorsia's EV-to-EBIT ratio for today is -41.06.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Idorsia's Enterprise Value is CHF2,760.2 Mil. Idorsia's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was CHF-50.3 Mil. Therefore, Idorsia's EV-to-EBITDA ratio for today is -54.82.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Idorsia's Enterprise Value is CHF2,760.2 Mil. Idorsia's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was CHF219.1 Mil. Therefore, Idorsia's EV-to-Revenue ratio for today is 12.60.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Idorsia's Enterprise Value is CHF2,760.2 Mil. Idorsia's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was CHF-119.2 Mil. Therefore, Idorsia's EV-to-OCF ratio for today is -23.16.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Idorsia's Enterprise Value is CHF2,760.2 Mil. Idorsia's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was CHF-134.4 Mil. Therefore, Idorsia's EV-to-FCF ratio for today is -20.53.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Idorsia  (XSWX:IDIA) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Idorsia's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2760.202/-67.222
=-41.06

Idorsia's current Enterprise Value is CHF2,760.2 Mil.
Idorsia's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-67.2 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Idorsia's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=2760.202/-50.346
=-54.82

Idorsia's current Enterprise Value is CHF2,760.2 Mil.
Idorsia's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-50.3 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Idorsia's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2760.202/219.094
=12.60

Idorsia's current Enterprise Value is CHF2,760.2 Mil.
Idorsia's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF219.1 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Idorsia's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=2760.202/-119.183
=-23.16

Idorsia's current Enterprise Value is CHF2,760.2 Mil.
Idorsia's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-119.2 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Idorsia's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2760.202/-134.443
=-20.53

Idorsia's current Enterprise Value is CHF2,760.2 Mil.
Idorsia's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-134.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Idorsia Enterprise Value Related Terms


Idorsia Enterprise Value Historical Data

* Premium members only.

The historical data trend for Idorsia's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Idorsia Enterprise Value Chart

Idorsia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,422.35 3,133.87 1,423.85 1,287.24 2,246.78

Idorsia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,395.93 1,659.89 2,198.48 2,246.78 2,106.18

XSWX:IDIA vs VRTX, REGN, ALNY: Enterprise Value Comparison

For the Biotechnology subindustry, Idorsia's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Idorsia Enterprise Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Idorsia's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Idorsia's Enterprise Value falls into.


XSWX:IDIA
49GF Score
Idorsia Ltd XSWX:IDIA
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Idorsia Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Idorsia's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Idorsia's Enterprise Value for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of CHF2,760.2 Mil mean?
Idorsia (XSWX:IDIA) has a Enterprise Value of CHF2,760.2 Mil as of Jun. 26, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Idorsia and its competitors.
Is Idorsia's Enterprise Value too high?
Idorsia's current Enterprise Value is CHF2,760.2 Mil. Overall, Idorsia has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Idorsia's Enterprise Value compare to VRTX and REGN?
Idorsia's Enterprise Value of CHF2,760.2 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Idorsia and its competitors. Idorsia's current Enterprise Value is CHF2,760.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Idorsia stock overvalued right now?
Based on GuruFocus' analysis, Idorsia (XSWX:IDIA) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF2.85, compared to a current price of CHF6.02 — trading 111.2% above its estimated fair value. The current Enterprise Value is CHF2,760.2 Mil. Idorsia's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Idorsia (XSWX:IDIA), the current Enterprise Value is CHF2,760.2 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Idorsia (XSWX:IDIA) Overvalued in 2026?

Based on GuruFocus' analysis, Idorsia stock appears to be overvalued. The current stock price of CHF6.02 is trading 111.2% above its estimated GF Value™ of CHF2.85. GuruFocus considers Idorsia to be Significantly Overvalued.

Key valuation signals for XSWX:IDIA:

  • Enterprise Value: CHF2,760.2 Mil
  • GF Value™: CHF2.85 vs. price of CHF6.02 (111.2% above fair value)
  • GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the XSWX:IDIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Idorsia Business Description

Address Hegenheimermattweg 91, Allschwil, CHE, 4123
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. The company is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide new therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. The company's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.
49GF Score

Get the complete analysis for XSWX:IDIA

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF6.02
Price
CHF2.85
GF Value